- GenScript Biotech Corporation has officially joined the Pharmaceutical Supply Chain Initiative (PSCI) as a Supplier Partner.
- This partnership will support GenScript’s commitment to advancing social responsibility and enhancing ESG (Environmental, Social, and Governance) standards in the pharmaceutical supply chain.
GenScript Biotech Corporation has become a Supplier Partner of the Pharmaceutical Supply Chain Initiative (PSCI), a global association dedicated to promoting responsible practices in the pharmaceutical industry. This milestone is part of GenScript’s ongoing efforts to integrate sustainability and ethics into its operations.
PSCI works with its partners to improve supply chain performance in key areas such as ethics, human rights, health and safety, and environmental management. Its widely respected guidelines for responsible supply chain management will now guide GenScript as it continues to enhance its global operations.
Sherry Shao, rotating CEO of GenScript Biotech Corporation, expressed the company’s pride in joining the PSCI. “Across our four key business areas—life sciences services and products, biologics contract development and manufacturing (CDMO), industrial synthetic products, and cell therapy—we are committed to driving innovation and progress, empowering the healthcare value chain.This partnership reflects our unwavering dedication to ethical practices, labor rights, health and safety, and environmental sustainability. By embedding PSCI principles into our operations, we aspire to work alongside our partners to enhance supply chain outcomes in social, health, safety, and environmental aspects, collectively shaping a more sustainable and responsible future for the global healthcare industry.”
GenScript’s adherence to PSCI principles will help ensure that its supply chain is both sustainable and compliant with high ESG standards. The company’s membership will support continued collaboration with customers and suppliers across diverse global markets, strengthening long-term partnerships.